Advertisement

Topics

INTELLIPHARMACEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Lawsuit Against IntelliPharmaCeutics International, Inc. - (IPCI)

22:52 EDT 4 Aug 2017 | FinanzNachrichten

NEW ORLEANS, LA--(Marketwired - August 04, 2017) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

Original Article: INTELLIPHARMACEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Lawsuit Against IntelliPharmaCeutics International, Inc. - (IPCI)

NEXT ARTICLE

More From BioPortfolio on "INTELLIPHARMACEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Lawsuit Against IntelliPharmaCeutics International, Inc. - (IPCI)"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...